Institutional members access full text with Ovid®

Share this article on:

Dietary Beliefs and Behavior Among Inflammatory Bowel Disease Patients

Zallot, Camille MD*; Quilliot, Didier MD, PhD; Chevaux, Jean-Baptiste MD*; Peyrin-Biroulet, Carina MD*; Guéant-Rodriguez, Rosa Maria MD, PhD*; Freling, Estelle MD*; Collet-Fenetrier, Benjamin MD*; Williet, Nicolas MD*; Ziegler, Olivier MD, PhD; Bigard, Marc-André MD*; Guéant, Jean-Louis MD, PhD*; Peyrin-Biroulet, Laurent MD, PhD*

doi: 10.1002/ibd.22965
Original Clinical Articles

Background: We investigated dietary beliefs and behavior in a large population of adult inflammatory bowel disease (IBD) patients and evaluated their impact on patients' social life.

Methods: A questionnaire of 14 items was administered to all consecutive IBD patients followed at the Nancy University Hospital Department of Gastroenterology from February to July 2011.

Results: A total of 244 patients participated in the survey; 15.6% (n = 38) of patients believed that diet could initiate the disease, while 57.8% (n = 141) believed that food can play a role in causing a relapse. Forty percent (107/244) of patients identified food as a risk factor for relapse. Seventy-three percent of respondents reported having already received nutritional advice. The majority of respondents (47.5%, n = 116) reported that the disease had changed the pleasure of eating. Only one-quarter of patients had a normal diet in case of relapse. Almost two out of three patients (66.8%, n = 163) reported not eating certain foods they usually like to eat in order to prevent a relapse. Dietary beliefs and behavior had an impact on their social life for one-fifth of patients. Excluding food was associated with refusing outdoor dining for fear of causing relapse (P = 0.006) and not sharing the same menu as the other members of the family living under the same roof (P = 0.002).

Conclusions: The majority of IBD patients are avoiding certain foods. Dietary beliefs and behavior have a strong impact on their social life.

Article first published online 29 March 2012

*Inserm, U954 and Department of Hepato-Gastroenterology, Nancy University Hospital, France

Department of Diabetes and Nutrition, Nancy University Hospital, France.

Reprints: Prof. Laurent Peyrin-Biroulet, MD, PhD, Inserm U954, and Department of Hepato-Gastroenterology, Nancy University Hospital, Allée du Morvan, 54511 Vandœuvre-lès-Nancy, France (e-mail: peyrinbiroulet@gmail.com).

The first two authors contributed equally.

Received February 07, 2012

Accepted March 05, 2012

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website